David Duffy Biography and Net Worth

SVP of Quanterix

David joined Quanterix in 2007 and leads the team of scientists developing its single-molecule detection technology.
He is an inventor on 12 U.S. patents and has more than 20 publications in the fields of surface chemistry, microfluidics, and bioanalysis. He was previously at Surface Logix, where he was the Director of Pharmacomer Technology. There David oversaw the development of a novel chemical technology that resulted in two drug candidates currently in Phase II clinical trials. Prior to that, David was at Gamera Biosciences where he was a co-inventor of a centrifugal microfluidic that was acquired and commercialized by Tecan. He was a postdoctoral research fellow in the Department of Chemistry and Chemical Biology at Harvard University. David was the first Sir Alan Wilson Research Fellow of Emmanuel College, University of Cambridge, and holds a Ph.D. in Physical Chemistry from the Department of Chemistry at the University of Cambridge.

What is David C. Duffy's net worth?: The estimated net worth of David C. Duffy is at least $502,982.25 as of December 18th, 2020. Dr. Duffy owns 42,807 shares of Quanterix stock worth more than $502,982 as of November 23rd. This net worth approximation does not reflect any other investments that Dr. Duffy may own. Additionally, Dr. Duffy receives an annual salary of $299,050.00 as SVP at Quanterix. Learn More about David C. Duffy's net worth.
How old is David C. Duffy?: Dr. Duffy is currently 53 years old. There are 6 older executives and no younger executives at Quanterix. The oldest executive at Quanterix is Dr. David R. Walt Ph.D., Co-Founder, Chairman of Scientific Advisory Board & Independent Director, who is 71 years old. Learn More on David C. Duffy's age.
What is David C. Duffy's salary?: As the SVP of Quanterix Co., Dr. Duffy earns $299,050.00 per year. There are 3 executives that earn more than Dr. Duffy. The highest earning executive at Quanterix is Dr. Masoud Toloue Ph.D., President, CEO & Director, who commands a salary of $957,030.00 per year. Learn More on David C. Duffy's salary.
How do I contact David C. Duffy?: The corporate mailing address for Dr. Duffy and other Quanterix executives is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. Quanterix can also be reached via phone at (617) 301-9400 and via email at [email protected]. Learn More on David C. Duffy's contact information.
Has David C. Duffy been buying or selling shares of Quanterix?: David C. Duffy has not been actively trading shares of Quanterix during the last quarter. Learn More on David C. Duffy's trading history.
Who are Quanterix's active insiders?: Quanterix's insider roster includes Amol Chaubal (CFO), Marijn Dekkers (Director), David Duffy (SVP), John Fry (General Counsel), E Hrusovsky (CEO), Dawn Mattoon (VP), and Mark Roskey (SVP). Learn More on Quanterix's active insiders.
Are insiders buying or selling shares of Quanterix?: During the last year, Quanterix insiders bought shares 1 times. They purchased a total of 47,000 shares worth more than $624,630.00. During the last year, insiders at the sold shares 2 times. They sold a total of 2,500 shares worth more than $60,025.00. The most recent insider tranaction occured on August, 20th when Director David R Walt bought 47,000 shares worth more than $624,630.00. Insiders at Quanterix own 6.9% of the company. Learn More about insider trades at Quanterix.
Information on this page was last updated on 8/20/2024.

David C. Duffy Insider Trading History at Quanterix

David C. Duffy Buying and Selling Activity at Quanterix

Quanterix Company Overview

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Today's Range

Now: $11.75

$11.58

$12.12

50 Day Range

MA: $12.86

$11.02

$15.49

2 Week Range

Now: $11.75

$10.50

$29.70

Volume

256,544 shs

Average Volume

476,778 shs

Market Capitalization

$450.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36

📉 Warning: Market Crash Predicted - Secure Your Savings

From Behind the Markets | Ad

The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.

Take these 4 steps to protect your retirement here >>>

David Duffy Biography and Net Worth

What is David C. Duffy's net worth?

How old is David C. Duffy?

What is David C. Duffy's salary?

How do I contact David C. Duffy?

Has David C. Duffy been buying or selling shares of Quanterix?

Who are Quanterix's active insiders?

Are insiders buying or selling shares of Quanterix?